PMID: 11921419Mar 29, 2002Paper

Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers

Diabetes/metabolism Research and Reviews
Anu-Maaria HämäläinenM Knip

Abstract

Cord blood samples were collected from 1002 consecutive births at Turku University Hospital to study the prevalence and fate of type 1 diabetes-associated autoantibodies in newborn infants of unaffected mothers. The samples were analysed for cytoplasmic islet cell antibodies (ICA), autoantibodies to the 65 kD isoform of glutamic acid decarboxylase (GADA), autoantibodies to the protein tyrosine phosphatase related IA-2 antigen (IA-2A), insulin autoantibodies (IAA) and HLA DQB1 genotypes. ICA were detected in 27 cord blood samples (2.7%), with a median of 6 (range 4-34) JDF units. GADA were found to be positive (> or =6.6 RU) in six samples (0.6%), with a median of 66 (range 19-125) RU. IA-2A (> or =0.43 RU) were observed in three samples (0.3%), with a median of 1.3 (range 0.8-57) RU, while only one cord blood sample (0.1%) tested positive for IAA (> or =1.56 nU/ml) with a value of 5.4 RU. Maternal or gestational age, sex and birth weight of the infant were not related to antibody prevalence or titres. Altogether there were 29 infants with antibody positivity in their cord blood (2.9%). Five of these (0.5%) tested positive for two antibodies (ICA and GADA), and one was positive for all four antibodies measured. All nine infants ...Continue Reading

References

Dec 1, 1979·Pediatric Research·A J TingleJ A Hunt
Sep 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·W D Billington
Jul 1, 1984·Diabetologia·U Di MarioD Andreani
Jul 19, 1984·The New England Journal of Medicine·J H WarramC R Kahn
Sep 1, 1994·Diabetologia·A Lernmark
Jan 1, 1993·Diabetes Care·P J BingleyE A Gale
Dec 1, 1996·Diabetes·A MartikainenH K Akerblom
Oct 31, 1997·Journal of Autoimmunity·A J WilliamsE A Gale
Apr 25, 2001·Diabetologia·A KupilaUNKNOWN Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland
Jun 26, 2001·Clinical and Experimental Immunology·M S RonkainenUNKNOWN Finnish Trigr Study Group

❮ Previous
Next ❯

Citations

Jan 5, 2007·Reviews in Endocrine & Metabolic Disorders·Hui Peng, William Hagopian
Mar 20, 2003·Current Diabetes Reports·Anu-Maaria Hämäläinen, Mikael Knip
Sep 24, 2004·Diabetes/metabolism Research and Reviews·Karin LarssonAke Lernmark
Jan 18, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Yariv YogevRaoul Orvieto
Jul 31, 2016·Schizophrenia Research·Philomena HallfordJun Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.